Several studies have demonstrated that dysregulation of EAAT3 expression or function can lead to various neurological disorders, including Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.40, 41. This evidence concerns the gene SLC1A1 and major depressive disorder.